Major vaccine companies shares have gone down as a result of Peter Marks resigning. Peter Marks is the FDA's top vaccine official and is resigning because of the decision of Health and Human Services and Robert F. Kennedy. Marks said RFK had negative views on vaccines and it was filled with misinformation and lies. Marks believes that a breakout in measles is a result of all this undermining in established vaccines. Investors and experts are worried about how these decisions are going to affect the FDA's role in approving safe medicines. Whether RFK and the Trump administration is right or wrong for the pushback against vaccines, the question is who is going to fill Peter Marks position. Many people believe with Marks gone the healthcare industry is going to face greater challenges
https://www.cnbc.com/2025/03/31/vaccine-stocks-fall-after-fdas-peter-marks-resigns-over-rfk-jr.html
3 comments:
I have seen RFK talk about vaccines. It is insane to me how he is now a top health official. I do not know if he realizes that the misinformation he peddles costs lives.
The resignation of Peter Marks, the FDA's top vaccine official, is undoubtedly a significant event that has raised concerns among investors and experts in the healthcare sector. Marks's departure, particularly after pressure from figures like Robert F. Kennedy Jr. (RFK), highlights the ongoing tensions around vaccine policies and public health. RFK Jr. has long been a critic of vaccines, claiming they are unsafe, a stance that Marks and many in the medical and scientific community have vigorously opposed, calling it misinformation that threatens public health. Investors are worried about the potential consequences of this change. The role of the FDA in approving safe and effective medicines is foundational to the healthcare industry, and uncertainty about who will replace Marks and how the FDA might evolve under new leadership creates a sense of instability. Any changes in the FDA’s vaccine approval process could affect not only vaccine manufacturers but also the broader healthcare landscape. Ultimately, with Marks's departure, the healthcare sector may face increased uncertainty, and how the FDA will adjust to these political and societal pressures remains to be seen. Investors, healthcare professionals, and the public will likely be watching closely to understand the future trajectory of vaccine policy and the FDA’s ability to safeguard public health.
I am still shocked that RFK has any real power. I would understand his appointment as a political move or whatever, but to give him actual power is insane when it comes to decisions that affect people's lives. I have seen him say horrible things about adderall for example but then turn around and talk about how heroin helped him focus in college and reach top of his class. Silly times.
Post a Comment